Position in LLY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$841,182,091
-$497,966,034 QoQ
Shares Held
914,557
-26.6% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
6.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026POLEN CAPITAL MANAGEMENT LLC holds $846,318,883 across 2 Drug Manufacturers - General names. LLY ranks #1 (99.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
914,557 | $841,182,091 | |
| 2 | AZN |
Astrazeneca PLC
|
26,046 | $5,136,792 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $841,182,091 | 914,557 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,339,148,125 | 1,246,090 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,238,323,821 | 1,622,967 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,354,752,982 | 1,737,910 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,449,117,734 | 1,754,571 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,000,040,308 | 1,295,389 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $434,070,732 | 489,955 | Shares | Sole | 2025-02-10 | |
| 2024-06-30 | $495,301,709 | 547,065 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $454,955,675 | 584,806 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $346,721,398 | 594,801 | Shares | Sole | 2024-05-10 | |
| 2023-09-30 | $335,068,139 | 623,812 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||